|

Dual-targeting BCMA-GPRC5D CAR-T cell infusion Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Beijing GoBroad Hospital1

Indications

  • Relapsed or Refractory Multiple Myeloma (RRMM)1
  • Cancer1

Other1 trial

Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.